1-4 of 4
Authors: Richard Reichman
Journal Article
Phase 2 Study of the Safety and Efficacy of Vicriviroc, a CCR5 Inhibitor, in HIV-1-Infected, Treatment-Experienced Patients: AIDS Clinical Trials Group 5211 Get access
The Journal of Infectious Diseases, Volume 196, Issue 2, 15 July 2007, Pages 304–312, https://doi.org/10.1086/518797
Published: 15 July 2007
Journal Article
Plasma HIV-1 RNA Dynamics in Antiretroviral-Naive Subjects Receiving either Triple-Nucleoside or Efavirenz-Containing Regimens: ACTG A5166s Get access
The Journal of Infectious Diseases, Volume 195, Issue 8, 15 April 2007, Pages 1169–1176, https://doi.org/10.1086/512619
Published: 15 April 2007
Journal Article
Changes in Virologic Markers as Predictors of CD4 Cell Decline and Progression of Disease in Human Immunodeficiency Virus Type 1-Infected Adults Treated with Nucleosides Get access
The Journal of Infectious Diseases, Volume 177, Issue 3, March 1998, Pages 625–633, https://doi.org/10.1086/514248
Published: 01 March 1998
Journal Article
Variability and Prognostic Values of Virologic and CD4 Cell Measures in Human Immunodeficiency Virus Type 1-Infected Patients with 200–500 CD4 Cells/mm3 (ACTG 175) Get access
The Journal of Infectious Diseases, Volume 177, Issue 3, March 1998, Pages 617–624, https://doi.org/10.1086/514250
Published: 01 March 1998
